MENU
EYPT
AS OF
Dec 24 closing price
Price
$18.26
Change
-$0.12 (-0.65%)
Capitalization
1.51B
69 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
EYPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

EyePoint (EYPT) Ownership - Who owns EyePoint?

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 617 926-5000
Employees
121
Web
https://www.eyepointpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.51B
P/E Ratio
N/A
Total Cash
204.02M
Projected Growth
N/A
Total Debt
21.3M
Revenue
42.34M
Risk (Beta)
3.27
Dividend Yield
N/A
Total Cash/Share
2.46
Total Debt/Equity
N/A
Revenue/Share
0.62 USD as % of share price

Fundamentals

EYPT
Capitalization
1.51B
P/E Ratio
N/A
Risk (Beta)
3.27
Dividend Yield
N/A
Total Cash
204M
Total Cash/Share
2.46
Total Debt
21.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.62%
Revenue
42.3M
ROE
N/A
Book Value
200M
P/B Ratio
7.55
Cash Flow
N/A
Earnings
-3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
70K
Current Ratio
7.18
Current Revenue Per Employee
65812.50
Dividends Per Share - Security
N/A
EBITDA
-201.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
25.36
Revenue To Assets
-74.47
Shares Held By Institutions
1.36B
Shares Outstanding - Current
82.8M
Total Liabilities
51.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
145.101
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
EYPT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EYPT showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for EYPT
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 617 926-5000
Employees
121
Web
https://www.eyepointpharma.com